Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

• Main Authors: Sara Salvador-Martín (Author), Bartosz Kaczmarczyk (Author), Rebeca Álvarez (Author), Víctor Manuel Navas-López (Author), Carmen Gallego-Fernández (Author), Ana Moreno-Álvarez (Author), Alfonso Solar-Boga (Author), Cesar Sánchez (Author), Mar Tolin (Author), Marta Velasco (Author), Rosana Muñoz-Codoceo (Author), Alejandro Rodriguez-Martinez (Author), Concepción A. Vayo (Author), Ferrán Bossacoma (Author), Gemma Pujol-Muncunill (Author), María J. Fobelo (Author), Antonio Millán-Jiménez (Author), Lorena Magallares (Author), Eva Martínez-Ojinaga (Author), Inés Loverdos (Author), Francisco J. Eizaguirre (Author), José A. Blanca-García (Author), Susana Clemente (Author), Ruth García-Romero (Author), Vicente Merino-Bohórquez (Author), Rafael González de Caldas (Author), Enrique Vázquez (Author), Ana Dopazo (Author), María Sanjurjo-Sáez (Author), Luis A. López-Fernández (Author)
• Format: Book
• Published: MDPI AG, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic markers that predict early response to anti-TNF drugs in pediatric patients with IBD. Methods: An o...